---
title: "Weekly Digest: Dec 14 - Dec 21, 2025"
date: 2025-12-21
description: "A curated summary of the top protein engineering and structure prediction signals from Dec 14 - Dec 21, 2025."
author: "Protein Design Digest"
tags: ["weekly", "digest", "protein-design"]
---

{{< newsletter >}}

# üß¨ Weekly Recap
**Dec 14 - Dec 21, 2025**

Missed a day? Here are the top research signals and tools from the past week, summarized for your Sunday reading.

---

## üèÜ Top Signals of the Week

## üóìÔ∏è Sunday, Dec 21

### [Enzyme Engineering Database (EnzEngDB): a platform for sharing and interpreting sequence-function relationships across protein engineering campaigns.](https://doi.org/10.1093/nar/gkaf1142)
#### üß¨ Abstract
The discovery and engineering of new enzymes is important across the bioeconomy, with diverse applications from foods to pharmaceuticals, sensors to agriculture. However, enzyme engineering, in particular machine learning-guided engineering, is hampered by a lack of data. Currently there exists no database designed to capture and interpret datasets created in this domain, nor are there easy analysis and visualisation tools. We developed the Enzyme Engineering Database to provide a centralized resource and an online analysis tool to consolidate sequence-function data from enzyme engineering campaigns, thereby making three contributions: (i) a database into which researchers can deposit public data, (ii) visualisation and analysis tools for protein engineers to analyse their own data or compare enzyme variants to other engineering campaigns, and (iii) a gold-standard dataset for benchmarking automated extraction along with the first large language model extraction pipeline specific for enzyme engineering campaigns. The Enzyme Engineering Database is accessible at http://enzengdb.org/.

> **Why it matters:** Expands the searchable sequence space for novel folds and high-affinity binders.

---

## ‚ö° Selected Quick Reads

- **[A multi-centre, multi-device benchmark dataset for landmark-based comprehensive fetal biometry](http://arxiv.org/abs/2512.16710v1)**: Accurate fetal growth assessment from ultrasound (US) relies on precise biometry measured by manually identifying anatomical landmarks in standard planes. Manual landmarking is time-consuming, operator-dependent, and sensitive to variability across scanners and sites, limiting the reproducibility of automated approaches. There is a need for multi-source annotated datasets to develop artificial intelligence-assisted fetal growth assessment methods. To address this bottleneck, we present an open, multi-centre, multi-device benchmark dataset of fetal US images with expert anatomical landmark annotations for clinically used fetal biometric measurements. These measurements include head bi-parietal and occipito-frontal diameters, abdominal transverse and antero-posterior diameters, and femoral length. The dataset contains 4,513 de-identified US images from 1,904 subjects acquired at three clinical sites using seven different US devices. We provide standardised, subject-disjoint train/test splits, evaluation code, and baseline results to enable fair and reproducible comparison of methods. Using an automatic biometry model, we quantify domain shift and demonstrate that training and evaluation confined to a single centre substantially overestimate performance relative to multi-centre testing. To the best of our knowledge, this is the first publicly available multi-centre, multi-device, landmark-annotated dataset that covers all primary fetal biometry measures, providing a robust benchmark for domain adaptation and multi-centre generalisation in fetal biometry and enabling more reliable AI-assisted fetal growth assessment across centres. All data, annotations, training code, and evaluation pipelines are made publicly available.

---

## üõ†Ô∏è Tools & Datasets

- üõ† **Tool**: [ChimeraX](https://www.rbvi.ucsf.edu/chimerax/) - Next-gen molecular visualization for large data sets.
- üíæ **Dataset**: [Uniprot Knowledgebase](https://www.uniprot.org/) - The world's most comprehensive resource for protein sequence and annotation.

---

## ü§ñ AI in Research Recap

- **[AlphaFold and the architecture that cracked protein structure - Interesting Engineering](https://news.google.com/rss/articles/CBMiiAFBVV95cUxQb2tCcnN4TThaSHJUN3hJVklDRk1kTHZpWTNVU0twV2ZXMEQ5eGNEZ2ZCMVJHMFdfSGtMRDRraXdaSTlEUlBqY2J3TWNsYVpNV2ZEWDR2N0wzX0ZMb1V1NGlhdWxVdkNUX2lPVzJCajB0SUtpZG5qeV9HWFNkMjJJNm9BVnMtRGsz?oc=5)**: AlphaFold and the architecture that cracked protein structure &nbsp;&nbsp; Interesting Engineering
- **[AI pinpoints new drug target for treating monkeypox virus - BioTechniques](https://news.google.com/rss/articles/CBMitgFBVV95cUxOalByWk5udkdDZVBfUTFUSTVFNDlDWWFJSmRfdGRHRzYxTkZuRzNtRkhqUUN4ZFVheEVNRUs0aTVsZWZ2OFRnSFljSWhydkdWV1lobGdtX0l6b19DbWZveEtSWElIdGhOQ0xRemYyZDJrSTI4MW5QZ2luTUVhdllnS2JNLVprMzdoUE5tS2FpZ1pCSl9lekc0eXBpbTNkdzRUWURUM0x0bk40Um1tQTBHVnNfdmd2Zw?oc=5)**: AI pinpoints new drug target for treating monkeypox virus &nbsp;&nbsp; BioTechniques
- **[Key Insights: Computational Structural Biology Workshop - Mirage News](https://news.google.com/rss/articles/CBMiiAFBVV95cUxNbVNHc2s0Z2JOWk9FOTZKSmZrQ3RYXzdJOHlUNWNzMHM1UFNvamdQc2tLZUdBeEQtMGV3bXBkYlVFVXpOdHc4bllHLUFGdzZhZG9TZEhJTjllbzJPcUZkRWxIR3c5Skp6Vi1ZZ1pPYlA0WmExY3BsVzZCQkk3cnJmTHVBZEhaV3dU?oc=5)**: Key Insights: Computational Structural Biology Workshop &nbsp;&nbsp; Mirage News

---

## üè¢ Industry & Real-World Applications

- **[Galux, Boehringer Ingelheim to Jointly Explore AI in Precision Protein Design - Contract Pharma](https://news.google.com/rss/articles/CBMivwFBVV95cUxOLTJXbVRmV1o5ZmszaExSN3l1TWY4VEREUHIwSzRKejFXRFY5STJzYnZEZzMtTEpsVjJYVGFkR25JekRPU0U1dkRzRFI4NG9NS2xQeDM2WFFsLXJiOWtBbjF5VjczMmdXYm1VdTg1YVZPd0dvWm5ZVUpJNWZWVHNTcWdoNWlOV2owbG9rVnhlbi1lMFRSM0xEa3dVMmUwZmpLVnBDcWVNc0UxR0xiRzc3UmNwRmF1NmpNNlhMR0R6UQ?oc=5)**: Galux, Boehringer Ingelheim to Jointly Explore AI in Precision Protein Design &nbsp;&nbsp; Contract Pharma
- **[Profluent Bio Partners with Ensoma for AI-Designed Base Editors in Stem Cell Therapies - SynBioBeta](https://news.google.com/rss/articles/CBMi7AFBVV95cUxOdU5Hd2x4R2lpVWJwelRYblNVeVNZUDFtSXZoaVc4bWMtRVRKNlRidnA5cjRLcmZBaWVrV3hhY3RpOVlzcFMwR2JSSG4xVnRfN3hlbWV0NkY2WEdWQVVuQWxTa3JPWmloTU5OTDhGYkJaeWpXR3JrU1JlZUhtdGNZb09id21EaEwwUzJ4UUoyanJFQnZNajhkMWFnTm40RUh1UDg0SXRld3FiMWs5OTJsb2hMb2twUHZGMU5BZzkwRnBHMWVrVEptbmI2bnM4MzJ6ZXB0NF80em43b25vNGpjamxRTDJEenFZLVppTQ?oc=5)**: Profluent Bio Partners with Ensoma for AI-Designed Base Editors in Stem Cell Therapies &nbsp;&nbsp; SynBioBeta
- **[Lindus Health, Quotient Sciences Partner to Accelerate Drug Development to Clinical Trials - Contract Pharma](https://news.google.com/rss/articles/CBMi0AFBVV95cUxNWUdWS3NHWXd4REFRX2ZOcjVPTDFfQUQxWmtsOVVrVFBleXVpbnBFSTRmZE5wY0ljQmVzRzdXRHJuX1I0SDF3QU0xZ19YQWlqbU9GX1lvTlZFTFBsVWVCOVcwek9ZRmxZTi01UUs3NHRKQkVNUU15cG1nc0hqM2hqMmc1XzBwTG1JcTFvNEszdzdnOW8xS0hFY0pBTThxamdLak1JQk0tMnI4YWJZSW9vQU5EbVhtZjNDZ1RuUHdNQzFIWDFmTTJ2V3BnMVJrMWpF?oc=5)**: Lindus Health, Quotient Sciences Partner to Accelerate Drug Development to Clinical Trials &nbsp;&nbsp; Contract Pharma

---

_Enjoyed this digest? Subscribe above to get these dailies in your inbox every morning._
